Hello, Guest
Login
Sign Up
 
 

Notable Stocks: Antares Pharma Inc, Dean Foods Company, Rentech, VirnetX Holding Corporation

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 02/28/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Antares Pharma Inc (NASDAQ:ATRS) shares jumped 5.04% and closed at $3.54 in the last trading session after the company yesterday said the New Drug Application for Otrexup, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration. Otrexup is being developed for self-administration of MTX to enhance the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis and psoriasis.

How Should Investors Trade ATRS After The Recent Movement? Find Out Here

Dean Foods Company (NYSE:DF) shares gained 4.79% to $16.18. The company, on Feb. 13, reported a net profit of $37 million, or 20 cents per share, for the quarter ended December. Total operating costs and expenses fell 15 percent to $644.9 million. Revenue rose 3 percent to $3 billion. Additionally, the company also forecasted a first-quarter profit of 22 cents to 27 cents per share. The company said it would cut fixed costs by closing 10 to 15 percent of its plants and eliminating many distribution routes.

Is DEF Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Rentech, Inc. (NYSE:RTK)shares climbed 4.78% and closed at $2.63. The company, on Jan. 22, announced that it will hold its 2012 4th quarter and year end conference call on Tuesday, March 19, 2013 at 11:00 a.m. PST, during which time ( Rentech's ) senior management will review the Company's financial results for the period and provide update on the business.

Is RTK a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

VirnetX Holding Corporation (NYSE:VHC) shares climbed 4.77% and closed at $35.58 after the company yesterday announced that on February 26, 2013, the United States District Court for the Eastern District of Texas, Tyler Division, issued its Memorandum Opinion and Order ("Order") regarding post-trial motions resulting from the prior $368 million jury verdict ("Verdict") for VirnetX in the ongoing patent infringement action between VirnetX Inc. ("VirnetX") and Apple Inc. ("Apple").

How Should Investors Trade VHC After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.